IDENTIFY FACTORS AFFECTING PREECLAMPSIA IN SELECTED AREA OF JHALAWAD

Abstract

Preeclampsia (PE) is one of the leading causes of maternal morbidity and mortality worldwide. Adequate knowledge about the disorder contributes significantly to its prevention, control and management. Preeclampsia affects 10% of pregnancies and is defined by the International Society for the Study of Hypertension in Pregnancy (ISSHP) as new-onset hypertension (≥140 mmHg systolic or ≥90 mmHg diastolic) after 20 weeks of pregnancy. This umbrella definition includes chronic hypertension, gestational hypertension, and preeclampsia (de novo or superimposed on chronic hypertension). Both of these conditions can have a significant impact on the health of the mother and fetus in the immediate and long term. For the mother, this includes a two- to four-fold increase in the risk of long-term hypertension, a doubling of the risk of cardiovascular mortality and major adverse cardiovascular events, and a 1.5-fold increase in the risk of stroke. For the fetus, this includes prenatal risks of intrauterine growth restriction (IUGR), preterm birth (most commonly iatrogenic), oligohydramnios, placental abruption, fetal distress, and fetal death in utero. There is also increasing evidence that exposure to hypertensive disorders of pregnancy in utero can result in significant long-term cardiovascular consequences in the offspring, including early-onset hypertension and increased risk of ischemic heart disease and stroke.

Keywords:

Dr. Sneha, awareness; hypertensive disorders of pregnancy, Malwanchal University